Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study

Introduction: Asthma and bronchiectasis appear to be two related diseases and in their complex inflammatory interaction, the cysteinyl leukotriene/cysteinyl leukotriene receptor 1 (cysLT/cysLTR1) axis appears to play an important role given its involvement also in the neutrophilic pathway. To our kn...

Descripción completa

Detalles Bibliográficos
Autores principales: Quaranta, Vitaliano Nicola, Dragonieri, Silvano, Crimi, Nunzio, Crimi, Claudia, Santus, Pierachille, Menzella, Francesco, Pelaia, Corrado, Scioscia, Giulia, Caruso, Cristiano, Bargagli, Elena, Kostikas, Konstantinos, Kyriakopoulos, Christos, Scichilone, Nicola, Carpagnano, Giovanna Elisiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410441/
https://www.ncbi.nlm.nih.gov/pubmed/36012941
http://dx.doi.org/10.3390/jcm11164702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410441/
https://www.ncbi.nlm.nih.gov/pubmed/36012941
http://dx.doi.org/10.3390/jcm11164702

Ejemplares similares